1. Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.
- Author
-
Bertelsen B, Melchior L, Jensen LR, Groth C, Glenthøj B, Rizzo R, Debes NM, Skov L, Brøndum-Nielsen K, Paschou P, Silahtaroglu A, and Tümer Z
- Subjects
- Animals, Attention Deficit Disorder with Hyperactivity genetics, Case-Control Studies, Chromosomes, Human, Pair 7 genetics, DNA Copy Number Variations, Denmark, Exons, Female, Gene Rearrangement, Genetic Predisposition to Disease, Humans, In Situ Hybridization, Fluorescence, Male, Mice, Microarray Analysis, Obsessive-Compulsive Disorder genetics, Sequence Analysis, DNA, Tics genetics, White People genetics, Endopeptidases genetics, Gene Deletion, Tourette Syndrome genetics
- Abstract
Tourette syndrome is a neurodevelopmental disorder characterized by multiple motor and vocal tics, and the disorder is often accompanied by comorbidities such as attention-deficit hyperactivity-disorder and obsessive compulsive disorder. Tourette syndrome has a complex etiology, but the underlying environmental and genetic factors are largely unknown. IMMP2L (inner mitochondrial membrane peptidase, subunit 2) located on chromosome 7q31 is one of the genes suggested as a susceptibility factor in disease pathogenesis. Through screening of a Danish cohort comprising 188 unrelated Tourette syndrome patients for copy number variations, we identified seven patients with intragenic IMMP2L deletions (3.7%), and this frequency was significantly higher (P=0.0447) compared with a Danish control cohort (0.9%). Four of the seven deletions identified did not include any known exons of IMMP2L, but were within intron 3. These deletions were found to affect a shorter IMMP2L mRNA species with two alternative 5'-exons (one including the ATG start codon). We showed that both transcripts (long and short) were expressed in several brain regions, with a particularly high expression in cerebellum and hippocampus. The current findings give further evidence for the role of IMMP2L as a susceptibility factor in Tourette syndrome and suggest that intronic changes in disease susceptibility genes should be investigated further for presence of alternatively spliced exons.
- Published
- 2014
- Full Text
- View/download PDF